4-iodophenylalanine has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gouverneur, E; Hellwig, D; Kirsch, CM; Menges, M; Raedle, J; Samnick, S; Schaefer, A | 1 |
| Amon, M; Feiden, W; Hellwig, D; Kirsch, CM; Kubuschok, B; Menger, MD; Romeike, BF; Samnick, S | 1 |
2 other study(ies) available for 4-iodophenylalanine and Cancer of Pancreas
| Article | Year |
|---|---|
Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Half-Life; Humans; Iodine Radioisotopes; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Pancreatic Neoplasms; Phenylalanine; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Whole-Body Irradiation | 2008 |
p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Humans; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Pancreatic Neoplasms; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2004 |